Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narihito Seki

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 18, 2007
[Update on and problems of the drug treatment for voiding dysfunction]Narihito Seki
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|January 18, 2006
[Prostatic diseases in aging men]Narihito Seki
Current Opinion in Urology|December 20, 2007
Holmium laser for benign prostatic hyperplasiaNarihito Seki, Seiji Naito
Current Opinion in Urology|December 5, 2006
Instrumental treatments for benign prostatic obstructionNarihito Seki, Seiji Naito
Nephro-Urology Monthly|April 11, 2013
Biofeedback therapy for stress urinary incontinence: is urodynamic assessment necessary?Narihito Seki, Nouval Shahab
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 9, 2002
[Aging and erectile dysfunction]Ryosuke Takahashi, Narihito Seki, Seiji Naito
Journal of Endourology|March 7, 2007
Holmium laser enucleation of the prostate: comparison of outcomes according to prostate size in 97 Japanese patientsNarihito Seki, Katsunori Tatsugami, Seiji Naito
Lower Urinary Tract Symptoms|April 26, 2017
Comparison of Silodosin versus Tadalafil in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic HyperplasiaMasaki Yoshida, Hideki Origasa, Narihito Seki
Neurourology and Urodynamics|May 25, 2006
Analysis of prognostic factors regarding the outcome after a transurethral resection for symptomatic benign prostatic enlargementNarihito Seki, Mineo Takei, Akito Yamaguchi, et al.
Lower Urinary Tract Symptoms|October 26, 2018
A 52-week multicenter randomized controlled study of the efficacy and safety of add-on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study)Tomonori Yamanishi, Hirotaka Asakura, Narihito Seki, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|May 18, 2007
[Update on and problems of the drug treatment for voiding dysfunction]Narihito Seki
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|January 18, 2006
[Prostatic diseases in aging men]Narihito Seki
Current Opinion in Urology|December 20, 2007
Holmium laser for benign prostatic hyperplasiaNarihito Seki, Seiji Naito
Current Opinion in Urology|December 5, 2006
Instrumental treatments for benign prostatic obstructionNarihito Seki, Seiji Naito
Nephro-Urology Monthly|April 11, 2013
Biofeedback therapy for stress urinary incontinence: is urodynamic assessment necessary?Narihito Seki, Nouval Shahab
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 9, 2002
[Aging and erectile dysfunction]Ryosuke Takahashi, Narihito Seki, Seiji Naito
Journal of Endourology|March 7, 2007
Holmium laser enucleation of the prostate: comparison of outcomes according to prostate size in 97 Japanese patientsNarihito Seki, Katsunori Tatsugami, Seiji Naito
Lower Urinary Tract Symptoms|April 26, 2017
Comparison of Silodosin versus Tadalafil in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic HyperplasiaMasaki Yoshida, Hideki Origasa, Narihito Seki
Neurourology and Urodynamics|May 25, 2006
Analysis of prognostic factors regarding the outcome after a transurethral resection for symptomatic benign prostatic enlargementNarihito Seki, Mineo Takei, Akito Yamaguchi, et al.
Lower Urinary Tract Symptoms|October 26, 2018
A 52-week multicenter randomized controlled study of the efficacy and safety of add-on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study)Tomonori Yamanishi, Hirotaka Asakura, Narihito Seki, et al.
Pageof 9